Endpoints News ٨ ديسمبر ٢٠٢٥ #ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?
Endpoints News ٢٥ نوفمبر ٢٠٢٥ Novartis was the sole bidder in $12B deal to buy Avidity #Avidity Biosciences #buy Avidity
Endpoints News ٢٤ نوفمبر ٢٠٢٥ #ASH25: Kelonia’s first in vivo CAR-T data; Lilly, J&J and Novartis spell out Phase 3 wins #American Society #wins Late-breaking